Modulation of Fatty Acid Transport and Metabolism by Maternal Obesity in the Human Full-Term Placenta1
| Autor: | Evemie Dubé, Guillaume Desparois, André Masse, Maude Ethier-Chiasson, Julie Lafond, Yves Giguère, Jean-Claude Forest, Coralie Martin, Issa Moussa, Ariane Gravel |
|---|---|
| Rok vydání: | 2012 |
| Předmět: |
Fetus
medicine.medical_specialty Lipoprotein lipase Apolipoprotein B biology Triglyceride Cholesterol CD36 Cell Biology General Medicine chemistry.chemical_compound medicine.anatomical_structure Endocrinology Reproductive Medicine chemistry Placenta Internal medicine biology.protein medicine lipids (amino acids peptides and proteins) Lipoprotein |
| Zdroj: | Biology of Reproduction. 87 |
| ISSN: | 1529-7268 0006-3363 |
| DOI: | 10.1095/biolreprod.111.098095 |
| Popis: | Knowledge of the consequences of maternal obesity in human placental fatty acids (FA) transport and metabolism is limited. Animal studies suggest that placental uptake of maternal FA is altered by maternal overnutrition. We hypothesized that high maternal body mass index (BMI) affects human placental FA transport by modifying expression of key transporters. Full-term placentas were obtained by vaginal delivery from normal weight (BMI, 18.5-24.9 kg/m(2)) and obese (BMI > 30 kg/m(2)) women. Blood samples were collected from the mother at each trimester and from cord blood at delivery. mRNA and protein expression levels were evaluated with real-time RT-PCR and Western blotting. Lipoprotein lipase (LPL) activity was evaluated using enzyme fluorescence. In vitro linoleic acid transport was studied with isolated trophoblasts. Our results demonstrated that maternal obesity is associated with increased placental weight, decreased gestational age, decreased maternal high-density lipoprotein (HDL) levels during the first and third trimesters, increased maternal triglyceride levels during the second and third trimesters, and increased maternal T3 levels during all trimesters, and decreased maternal cholesterol (CHOL) and low-density lipoprotein (LDL) levels during the third trimester; and increased newborn CHOL, LDL, apolipoprotein B100, and T3 levels. Increases in placental CD36 mRNA and protein expression levels, decreased SLC27A4 and FABP1 mRNA and protein and FABP3 protein expression, and increased LPL activity and decreased villus cytotrophoblast linoleic acid transport were also observed. No changes were seen in expression of PPARA, PPARD, or PPARG mRNA and protein. Overall this study demonstrated that maternal obesity impacts placental FA uptake without affecting fetal growth. These changes, however, could modify the fetus metabolism and its predisposition to develop diseases later in life. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|